In fact, both their actions as dual PPAR agonists and as inhibitors of the aforementioned cholinesterase enzymes have been proven to counteract cognitive impairment in AD animal models (Aksoz, Akyol, and Korkut 2024; Sato et al. 2011; Wójtowicz et al. 2020). Here, PPARA is linked to Alzheimer disease.